(19)
(11) EP 2 405 755 A1

(12)

(43) Date of publication:
18.01.2012 Bulletin 2012/03

(21) Application number: 10751135.4

(22) Date of filing: 11.03.2010
(51) International Patent Classification (IPC): 
A01N 43/42(2006.01)
A61K 31/44(2006.01)
(86) International application number:
PCT/US2010/000750
(87) International publication number:
WO 2010/104595 (16.09.2010 Gazette 2010/37)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 11.03.2009 US 159429 P
11.03.2009 US 159423 P
11.03.2009 US 159427 P

(71) Applicant: Xintria Pharmaceutical Corporation, Inc.
Washington, DC 20006-3700 (US)

(72) Inventor:
  • LIPPA, Arnold, Stan
    Ridgewood, NJ 07450 (US)

(74) Representative: Atkinson, Jennifer 
Barker Brettell LLP 100 Hagley Road
Edgbaston Birmingham B16 8QQ
Edgbaston Birmingham B16 8QQ (GB)

   


(54) METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC AND CARDIOVASCULAR DISORDERS